主页 > 医学文档 >

【medical-news】纳米技术将为肝癌带来新的治疗方

Nanotechnology May Lead to New Treatment of Liver Cancer

Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.

Researchers evaluated the use of molecular-sized bubbles filled with C6-ceramide, called cerasomes, as an anti-cancer agent. Ceramide is a lipid molecule naturally present in the cell's plasma membrane and controls cell functions, including cell aging, or senescence.

Hepatocellular carcinoma is the fifth most common cancer in the world and is highly aggressive. The chance of surviving five years is less than five percent, and treatment is typically chemotherapy and surgical management including transplantation.

"The beauty of ceramide is that it is non-toxic to normal cells, putting them to sleep, while selectively killing cancer cells," said Mark Kester, Ph.D., G. Thomas Passananti Professor of Pharmacology.

Cerasomes, developed at Penn State College of Medicine, can target cancer cells very specifically and accurately, rather than affecting a larger area that includes healthy cells. The problem with ceramide is that as a lipid, it cannot be delivered effectively as a drug. To solve this limitation, the researchers use nanotechnology, creating the tiny cerasome, to turn the insoluble lipid into a soluble treatment.

"Cerasomes were designed as a therapeutic alternative to common chemotherapeutics," said Kester. "These have been shown to be toxic to cancer cells and not to normal cells, and have already been shown to effectively treat cellular and animal models of breast cancer and melanoma. Cerasomes have also been shown to be essentially free of toxic side effects normally associated with anticancer agents."

In the test tube and animal models of liver cancer, cerasomes, but not a placebo, selectively induced cell death in the cancer cells.

In mice with liver cancer, cerasomes blocked tumor vascularisation, the forming of blood vessels needed for growth and nutrition. Studies show that lack of nutrition causes cells to create more ceramide and leads to cell death.

"It is plausible that preventing liver tumor vascularization with cerasome treatment could induce widespread apoptosis, a genetically programmed series of events that leads to cell death in tumors," Kester said. "The efficacy of our cerasomes in the treatment of diverse cancers lends significant therapeutic promise as it translates from bench to bedside."

The researchers published their work in the journal Gut. A Penn State Dean's Feasibility Grant, Pennsylvania tobacco settlement funds, and the National Institutes of Health supported this work.

In an earlier study published in the journal Blood, researchers observed that cerasome use led to complete remission in aggressive, large granular lymphocytic leukemia in rats. In addition, the protein survivin, which prevents cell death, is heavily produced in NK-leukemia cells, but not in normal cells. Cerasome decreased expression of survivin and may lead to a therapeutic approach for fatal leukemia.

Other researchers are Hephzibah Rani S. Tagaram, M.D., Diego Avella, M.D, Eric. T. Kimchi, M.D., and Kevin F. Stavely O'Carroll, M.D., Department of Surgery; Nicole A. DiVittore, Brian M. Barth, Ph.D., and James M. Kaiser, Department of Pharmacology; Yixing Jiang, M.D., Ph.D., Department of Medicine; and Harriet C. Isom, Ph.D., Department of Microbiology and Immunology.

http://www.sciencedaily.com/releases/2011/02/110222122200.htm 欢迎大家积极提供生物及生命工程信息 - 业界热点资讯版 - 爱爱...发表时间:2010-12-19回帖数:0生物及医学新闻我们必须客观科学面对,不能来半点需要,这是做医生起码原则,现在我欢迎... 每日动态汇总http://news.dxy.cn/bbs/topicwww.iiyi.com/bbs/thread-191... - 2011-02-08-快照-生命工程信息 - 业界热点资讯版 - 爱爱..." 生命科学研究快报文件类型:DOC/Microsoft Word- 文字版生命科学研究快报 2004年第25期(总第60期) (仅供内部参考) 目录 【科技发展动态:科技... 特别是治疗血癌和其他癌症.但是应用该技术修复心脏疾病破坏的组织是最新的进展. ...www.library.sh.cn/...04/60.doc-2010-07-28-生命科学研究快报" 染色体 | 生命奥秘因此我们必须找到新的方法来应对这种不确定性. 第三, 这种人工合成生命体的新技术也... http://www.sciencedaily.com/releases/2010/05/100514094834.htm 科学家发现凝集蛋白...www.lifeomics.com/...d=2&s=染色体-2010-07-28-快照-生命奥秘"[标签:content2]

阅读本文的人还阅读:

【科普】新式打印机能“

【公共卫生 - 统计】米国

【技术产业】宝洁公司创

【科技新闻】New evidenc

【medical-news】最新研究表

作者:admin@医学,生命科学    2011-02-28 00:59
医学,生命科学网